Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content
Archive

Table A4. Government Performance and Results Act (GPRA) Sexually Transmitted Diseases Goals, Measures, and Target

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 


GPRA GoalsActualTarget
2009201020112012
Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15–44 years of age)100,000113,00090,000100,533
a. Proportion of high-risk women aged 16–20 infected with chlamydia*12.9012.6511.6112.53
b. Proportion of high-risk women aged 21–24 infected with chlamydia*8.517.697.697.97
c. Rate of Gonorrhea/100,000 population in women aged 16-20664.8658.8663714.56
d. Rate of Gonorrhea/100,000 population in women aged 21-24491.7505.4536.9533.41
e. Black: white ratio of gonorrhea in women 16-2414.613.913.613.16
f. Proportion of sexually active females 16-20 enrolled in Medicaid who are screened for chlamydia infections54.454.6N/A60.0
g. Proportion of sexually active females 21-24 enrolled in Medicaid who are screened for chlamydia infections61.662.3N/A69.4
h. Proportion of sexually active females 16-20 enrolled in commercial health insurance plans who are screened for chlamydia infections41.040.8N/A48.7
i. Proportion of sexually active females 21-24 enrolled in commercial health insurance plans who are screened for chlamydia infections45.445.7N/A54.8
Goal 2: Elimination of Congenital Syphilis
a. Incidence of P&S syphilis/100,000 population in women aged 15-443.12.52.13.0
b. Incidence of congenital syphilis/100,000 live births10.19.18.510.05
c. Proportion of pregnant women that are screened for syphilis at least
one month before delivery		N/A84.8N/A80.60

GPRA Goals
1National Disease and Therapeutic Index (IMS Health)
1a, 1bNational Job Training Program
1c, 1d, 1eSTD Surveillance System (STDSS), NCHHSTP, CDC
1f, 1g, 1h, 1iHealthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA)
2a, 2bSTD Surveillance System (STDSS), NCHHSTP, CDC
2cMarketscan. Thomson Reuters (Healthcare) Inc.

*Median state-specific chlamydia prevalence/positivity.

GPRA= Government Performance and Results Act; PID= pelvic inflammatory disease; P&S= primary and secondary.

Top